Skip to content

A non-invasive diagnosis system for liver inflammation was established based on the LivQ-box® parameters of iLivTouch

A non-invasive diagnosis system for liver inflammation was established based on the LivQ-box® parameters of iLivTouch

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106252
Enrollment
Unknown
Registered
2025-07-21
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis

Interventions

Gold Standard:Liver biopsy was performed to evaluate liver inflammation according to the GS scoring system, the Metavir scoring system and the Ishak scoring system

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Applicants must be over 18 years old, regardless of gender; 2) Patients with chronic liver inflammation (chronic hepatitis B, fatty liver hepatitis) confirmed by previous liver puncture, and can Patients who obtained liver biopsies or pathology pictures/reports; 3) Patients who have undergone iLivTouch within 7 days of the +- of the liver puncture and the results can be exported; 4) Patients with access to demographic, biochemical, and etiological information within 7 days before and after hepatopesis.

Exclusion criteria

Exclusion criteria: 1) Combined with other chronic liver diseases (drug-induced liver injury, alcoholic liver disease, autoimmune liver disease, sequelae metabolic liver disease, etc., but excluding fatty liver); 2) Taking drugs that may directly affect liver function test indicators within one month (such as dicyclic alcohol, pentaesters drop pills, packets traditional Chinese medicine containing Schisandra chinensis, silymarin, glycyrrhizin, polyene phosphatidylcholine, etc.); 3) 50% of patients with missing demographic, biochemical, and etiological information >;

Design outcomes

Primary

MeasureTime frame
RF parameters;

Secondary

MeasureTime frame
Accuracy;Sensitivity;Specificity;Positive predicative value;Negative predicive value;

Countries

China

Contacts

Public ContactXiaoning Wu

Beijing Friendship Hospital Affiliated to Capital Medical University

wuxiaoningbs@126.com+86 134 3956 1979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026